Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
Perion Network
PERI
$372M
| $161K | ﹤0.01% |
20,427
-8,287
| -29% | -$69.4K |
|
4277
GrowGeneration
GRWG
$87.1M
| $161K | ﹤0.01% |
75,452
+55,290
| +274% | +$119K |
|
4278
908 Devices
MASS
$324M
| $160K | ﹤0.01% |
46,214
+37,853
| +453% | +$168K |
|
4279
Bitdeer Technologies
BTDR
$2.63B
| $160K | ﹤0.01% |
+20,450
| New | +$170K |
|
4280
LiveWire
LVWR
$362M
| $160K | ﹤0.01% |
26,210
+19,474
| +289% | +$133K |
|
4281
Innovator US Equity Power Buffer ETF March
PMAR
$759M
| $160K | ﹤0.01% |
+4,066
| New | +$156K |
|
|
ARIS
4282
Aris Mining
ARIS
$2.78B
| $159K | ﹤0.01% |
34,656
+32,256
| +1,344% | +$142K |
|
|
CTNM
4283
Contineum Therapeutics
CTNM
$576M
| $159K | ﹤0.01% |
8,308
+5,925
| +249% | +$114K |
|
4284
Sagimet Biosciences
SGMT
$446M
| $159K | ﹤0.01% |
57,230
+7,178
| +14% | +$22.1K |
|
4285
Idaho Strategic Resources
IDR
$451M
| $158K | ﹤0.01% |
9,840
+9,749
| +10,713% | +$117K |
|
4286
Harvard Bioscience
HBIO
$27.2M
| $158K | ﹤0.01% |
5,866
+4,415
| +304% | +$130K |
|
4287
Invesco S&P 500 GARP ETF
SPGP
$2.25B
| $157K | ﹤0.01% |
1,500
| – | – |
|
4288
Fennec Pharmaceuticals
FENC
$332M
| $157K | ﹤0.01% |
31,319
+22,951
| +274% | +$133K |
|
4289
INmune Bio
INMB
$46.8M
| $157K | ﹤0.01% |
29,044
+24,906
| +602% | +$177K |
|
|
YALA
4290
Yalla Group
YALA
$817M
| $156K | ﹤0.01% |
34,460
-9,177
| -21% | -$38.4K |
|
|
EFXT
4291
Enerflex
EFXT
$2.73B
| $156K | ﹤0.01% |
26,169
+26,168
| +2,616,800% | +$147K |
|
|
JUNM
4292
FT Vest U.S. Equity Max Buffer ETF - June
JUNM
$66.7M
| $156K | ﹤0.01% |
+4,959
| New | +$153K |
|
4293
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$157M
| $155K | ﹤0.01% |
+4,366
| New | +$152K |
|
4294
Innovator US Equity Buffer ETF June
BJUN
$314M
| $154K | ﹤0.01% |
+3,793
| New | +$150K |
|
|
CMBT
4295
CMB.TECH NV
CMBT
$4.68B
| $154K | ﹤0.01% |
9,259
-36,499
| -80% | -$600K |
|
4296
Acumen Pharmaceuticals
ABOS
$155M
| $154K | ﹤0.01% |
61,997
+40,551
| +189% | +$110K |
|
4297
InnovAge Holding
INNV
$1.55B
| $154K | ﹤0.01% |
25,614
+19,029
| +289% | +$113K |
|
4298
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.4B
| $154K | ﹤0.01% |
2,385
| – | – |
|
4299
Frequency Electronics
FEIM
$572M
| $153K | ﹤0.01% |
+12,693
| New | +$154K |
|
4300
SkinHealth Systems
SKIN
$86.9M
| $153K | ﹤0.01% |
106,103
+73,425
| +225% | +$120K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.